| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |